| |
| |
|
| Insider
Information: |
Riedel Norbert G |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
854,950 |
|
|
Indirect Shares
|
740,608 |
|
|
| Direct
Value |
$5,754,680 |
|
|
|
Indirect Value
|
$71,098 |
|
|
| Total
Shares |
1,595,558 |
|
|
| Total
Value |
$5,825,778 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -38.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Baxter International Inc |
BAX |
Corporate Vice President |
2013-01-16 |
56,689 |
2005-03-14 |
0 |
Premium* |
|
|
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
1,340 |
2006-06-08 |
0 |
Premium* |
|
|
Ariad Pharmaceuticals Inc |
ARIA |
Director |
2016-02-01 |
121,859 |
2011-04-28 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
13,705 |
2013-05-09 |
0 |
Premium* |
|
|
Aptinyx Inc. |
APTX |
|
2021-12-06 |
615,265 |
2021-12-06 |
740,608 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2023-06-07 |
46,092 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APTX |
Aptinyx Inc. |
CEO |
• • – |
2021-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
380,000 |
742,539 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO |
• • – |
2021-05-17 |
4 |
D |
$2.53 |
$322,003 |
D/D |
(127,274) |
615,265 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
116,481 |
323,976 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO |
• • – |
2021-12-06 |
4 |
B |
$2.23 |
$223,000 |
I/I |
100,000 |
100,000 |
0.01 |
% |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2009-12-02 |
4 |
OE |
$27.13 |
$3,146,425 |
D/D |
92,500 |
128,924 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2009-12-02 |
4 |
S |
$55.92 |
$5,172,600 |
D/D |
(92,500) |
36,424 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2009-01-27 |
4 |
OE |
$41.34 |
$3,307,200 |
D/D |
80,000 |
92,399 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2009-01-27 |
4 |
S |
$58.09 |
$4,647,200 |
D/D |
(80,000) |
38,099 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2010-03-05 |
4 |
S |
$59.29 |
$4,482,324 |
D/D |
(75,600) |
50,248 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2010-03-05 |
4 |
OE |
$49.54 |
$3,745,224 |
D/D |
75,600 |
125,848 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2012-08-03 |
4 |
OE |
$38.35 |
$2,689,294 |
D/D |
70,125 |
122,940 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2012-08-03 |
4 |
S |
$58.99 |
$4,136,674 |
D/D |
(70,125) |
52,815 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2007-06-05 |
4 |
S |
$57.50 |
$3,138,885 |
D/D |
(54,584) |
40,418 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2007-06-05 |
4 |
OE |
$30.06 |
$1,675,725 |
D/D |
54,584 |
95,002 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2007-06-06 |
4 |
S |
$57.40 |
$2,278,780 |
D/D |
(39,700) |
40,418 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2007-06-06 |
4 |
OE |
$27.13 |
$1,096,106 |
D/D |
39,700 |
80,118 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2018-11-12 |
4 |
OE |
$2.59 |
$99,878 |
D/D |
38,563 |
362,539 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2020-01-10 |
4 |
B |
$3.00 |
$105,000 |
I/I |
35,000 |
35,000 |
2.66 |
% |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2009-01-26 |
4 |
OE |
$41.34 |
$921,882 |
D/D |
22,300 |
60,399 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2009-01-26 |
4 |
S |
$58.00 |
$1,293,400 |
D/D |
(22,300) |
38,099 |
0 |
- |
|
| BAX |
Baxter International Inc |
Corporate Vice President |
• – – |
2010-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
56,424 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Director |
– • – |
2011-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,000 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,270 |
28,540 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,270 |
42,810 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
84,359 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
